Catanzaro, Tavi also to the Apulian: new mini-invasive frontier against aortic stenosis

John

By John

Another step forward in highly specialized cardiological assistance in Catanzaro. The “Apulian” Hospital of the Hospital-University “Renato Dulbecco” Hospital, it is possible to carry out the percutaneous system of organic aortic valve (TAVI), a mini-invasive procedure that allows you to treat severe aortic stenosis without opening the chest, but through a catheter inserted by the patient grove.

It is a strengthening of the corporate offer, since the Tavi procedure is already regularly performed at the Cardiology UOC of the Germaneto area, directed by Professor Daniele Torellaand that now, with the activation of the Apulian, consolidates the integrated assistance network of the Oou “Renato Dulbecco”, directed by the extraordinary commissioner, Dr. Simona Carbone.

With great satisfaction, the Professor Vincenzo Antonio CiconteDirector of the UOC of Cardiology of the “Apulian” Po, announced that in recent days the first patients have been successfully treated, some of whom have already been discharged in excellent health.

The procedures were performed by Dr. Annalisa Mongiardooperator with consolidated experience in the Tavi, and by the Dr. Cristina Nesta.

A concrete response against health emigration

The activation of the Tavi also to the Apulian represents a concrete response to the serious health emigration that every year involves thousands of Calabrians forced to move out of the region to receive specialist treatments. The discomfort of patients is thus reduced, the quality of the health offer is raised and the economic deficit of Calabrian healthcare is argine.

According to current international guidelines, Tavi is indicated in patients with severe, symptomatic aortic stenosis, over the age of 75, or in those who, regardless of age, have high surgical risk. In light of the most recent scientific studies, an expansion of the indications to the percutaneous procedure is also expected in patients at intermediate or bass risk.

A multidisciplinary team work

The success of the first procedures to the Apulian pole was made possible thanks to the coordinated work of an entire team: the hemodynamics room, led by Doctor Antonio Ferraroand the technical-infirmary staff under the supervision of Ivan Critellihave guaranteed the best operating conditions.

The support of doctors and nursing staff of the Cardiology and UTIC department, engaged in the post-operative preparation and management of patients, as well as the collaboration with the UOC of Radiology, directed by the Dr. Bernardo Bertuccifor the execution of the dedicated CTS, and with echocardiographists and staff of the clinic for diagnosis and follow-up.

No less important, the role of the cardiac surgery UOC, directed by Professor Pasquale Mastrorobertoan integral part of the corporate Heart Team, which shares the indications for the intervention and guarantees cardiac surgery. Equally strategic the presence of the UOC of Anesthesia of the Apulian Po, directed by Dr. Stefania Faragòand the contribution of 118, which ensures prompt intervention in case of need.

A success resulting from the synergy between institutions and professionalism

The management of the “Renato Dulbecco”, from the Rector of the Magna Graecia Universityfrom the President of the Calabria Region, honorable Roberto Occhiutoand from Extraordinary Commissioner of the Aou, Dr. Simona Carbone.

“The strengthening of the Tavi procedure also at the Apulian garrison – reads a note – is the concrete result of an integrated vision and a functional synergy between professionalism and structures within the company. Thanks to the collaboration between the directors of the two cardiologies, Professor Vincenzo Antonio Ciconte And Professor Doctor Daniele Torellawho have been able to harmonize resources, experiences and skills to give a concrete and innovative answer to the health demand in cardiovascular field ».

A further step forward that places the Aou “Renato Dulbecco” as a regional and national reference point in the adoption of innovative technologies for the treatment of valve pathologies.